Adgang til aktieinformation, aktienyheder, selskabsledelser og analytikere.

I dagens Morgenbørs ser vi ind i forholdsvis flade futures med en marginalt positiv stemning i Europa og en marginalt negativ stemning i USA. Herhjemme er der fokus på blandt andet Novo Nordisk og Ørsted.

Dagens aktienyheder med Trifork, ISS, Rovsing og Agillic

Aiforia announced on Monday that it has appointed Antti Ojala as the company's new CFO and a member of the management team.

However, CapMan did not disclose the size of the first closing, so it is not possible to assess the company's success at this point.

Relais' subsidiary Strands Group will acquire 70% of Qpax AB.

Curasight has entered a new clinical phase with both arms of its uPAR-based theranostic platform now in clinical development, following the successful first patient dosing in the Phase I uTREAT® trial in glioblastoma and continued progress in the Phase II uTRACE® prostate cancer study under the partnership with Curium. With diagnostic proof-of-concept already established across multiple indications, the transition of uTREAT® into human trials materially expands the company’s addressable market and shifts investor focus toward the therapeutic upside embedded in the platform.

We believe the share is attractively priced.

I dagens Morgenbørs ser vi ind i et asiatisk marked, hvor specielt Japan og Korea er kørt pænt op på et AI-rebound i nat. Futures i USA peger op imens Europa er mere fladt her til morgen.

Dagens aktienyheder 22/12-2025: Gomspace og ExpreS2ion Biotechnologies

The project is relatively small for the company in terms of size, but it is a strategically important reference in Sweden's growing rail market.

The acquired company specializes in damage repair for heavy commercial vehicles in Northern Sweden.

Solwers announced on Friday its second acquisition within 24 hours, as its Swedish subsidiary WiseGate AB agreed to acquire the entire share capital of Odigo Consulting AB.

Preliminary Swedish clothing market data for December sales up to the 16th were down 8.4%. Although we believe that the figures was relativley weak, the period is quite short, so it can be affected by various factors such as the timing of Black Week sales.

Sweden, pulses, BlackGrain, and vegetable oils are key growth themes.

ExpreS2ion today reported updated immunogenicity data from the first three patients treated with its HER2-targeted breast cancer vaccine candidate ES2B-C001, alongside confirmation that the independent Data Safety Monitoring Board (DSMB) has reviewed safety data and recommended progression to the next dose cohort in the ongoing Phase I trial.

Talenom issued a profit warning, published Easor's listing prospectus, acquired three small accounting firms in Spain, provided guidance for both businesses for next year, and organized an investor webcast.

I dagens Morgenbørs ser vi ind i små fald i den europæiske åbning trods gode takter i Asien. Herhjemme fokus på Curasight og GreeMobility.

Dagens aktienyheder 19/12-2025: Roblon, GreenMobility og Curasight